GORYO Chemical, Inc
- Kenichi Maruyama
Development of fluorescent probes for quick diagnosis during cancer surgery
GORYO Chemical, Inc is developing cancer diagnostics with fluorescent probes discovered by Prof. Urano in Tokyo Univ. These probes are the so called “activatable fluorescent probes”. Activatable fluorescent probes can detect the analyte with high S/N ratio and brightness because the probes do not show any fluorescence at all if the target is absent. These probes will contribute to reduce insufficient excision of tumor and reduce surgery time as they can detect the cancer cells within 1 minute.
GORYO Chemical, Inc was established in 2010 in Sapporo, Hokkaido to develop fluorescent probes not only for research reagents but also for medical use, on the basis of chemical biotechnology.
Goryo has platform technologies of fluorescent dyes for diagnostics, which were initially developed by Urano Laboratory of the University of Tokyo. GORYO has also the capability of synthesizing these dyes efficiently.
UTEC value up
Hands-on support such as brush up our business plan, financing, recruiting to promote short- and long-term growth
Detection of cancer cells using gGlu-HMRG fluorescence
Human ESD (Endoscopic Submucosal Dissection) cancer samples at each reaction state with EP-HMRG (before spraying EP-HMRG (left), after 5 min (middle) and after 10 min (right))